Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263)
Condition(s):Osteoporosis PostmenopausalLast Updated:February 8, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Osteoporosis PostmenopausalLast Updated:February 8, 2022Completed
Condition(s):Osteoporosis, PostmenopausalLast Updated:December 3, 2020Unknown status
Condition(s):OsteoporosisLast Updated:February 8, 2022Completed
Condition(s):HealthyLast Updated:July 9, 2009Completed
Condition(s):Cystic Fibrosis; Osteoporosis; Bone Diseases, MetabolicLast Updated:October 23, 2008Completed
Condition(s):Breast NeoplasmsLast Updated:October 22, 2020Terminated
Condition(s):OsteoporosisLast Updated:August 12, 2009Terminated
Condition(s):OsteoporosisLast Updated:September 29, 2021Completed
Condition(s):Postmenopausal OsteoporosisLast Updated:September 29, 2023Active, not recruiting
Condition(s):Breast Carcinoma; CalcificationLast Updated:June 22, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.